ANIX
Anixa Biosciences Inc
2.80$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -348.0% | – | – | – | – | – | – | – | – | – | |
| – | +7.4% | +6.2% | +2.8% | -6.7% | +35.7% | -80.7% | -33.4% | -30.0% | +9.5% | -19.6% | -389.2% | |
| – | -15.0% | -67.4% | +91.6% | +412.6% | -35.7% | -28.9% | +91.3% | -20.0% | -26.3% | 0.0% | -16.7% | |
| – | -51.6% | -67.0% | -77.1% | +2,936.4% | -36.8% | +4.0% | +90.4% | -15.5% | – | – | – | |
| – | – | – | – | -83.4% | +606.7% | -195.9% | – | +521.8% | -318.6% | – | -71.1% | |
| – | +719.5% | +167.5% | -79.4% | +27.2% | +356.9% | -91.0% | -100.0% | – | – | – | – | |
| – | – | +3,224.5% | -281.9% | – | -136.0% | -41.8% | +1,180.9% | +173.9% | -47.8% | – | +13.8% | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -2,815.0% | – | -4,337.3% | – | +125.0% | +65.4% | – | – | -100.0% | – | -100.0% | |
| – | -185.7% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | -105.5% | -99.3% | – | -65.8% | +125.5% | +65.0% | +235.6% | -98.6% | -19.0% | +833.1% | -33.2% | |
| – | -59.1% | -286.6% | – | -133.3% | – | +571.4% | +676.3% | -173.8% | – | – | -107.6% | |
| – | – | -369.6% | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.